Suppr超能文献

磁县食管癌高危人群的年龄范围。

Age scope of high-risk population for esophageal cancer in Ci county.

作者信息

Chen Zhi-Feng, Hou Jun, Ding Zhen-Wei, Guo Cui-Lan, Qiao Cui-Yun, Song Guo-Hui, Li Shao-Sen, Zhang Jian-Hui, He Yu-Tong

机构信息

Hebei Cancer Institute, Shijiazhuang 050011, Hebei Province, China.

出版信息

World J Gastroenterol. 2005 Mar 28;11(12):1818-21. doi: 10.3748/wjg.v11.i12.1818.

Abstract

AIM

To define the age scope of high-risk population for esophageal cancer (EC) in Ci county.

METHODS

The results of endoscopic examination of 2 013 subjects, cytological screening of 16 763 persons and records of 9 265 patients with EC were analyzed by Ridit methods, the standard age group was 45-49 year group.

RESULTS

The average age of patients with moderate esophageal epithelium dysplasia by endoscopic examination was 53.5 years, of severe esophageal epithelium dysplasia, 51.4 years, early EC, 55.6 years. The average age of stage one severe epithelium dysplasia (SEEDI) by cytological screening was 51.2 years, of stage two severe epithelium esophageal dysplasia (SEED II) 51.6 years, of advanced EC 61.7 years. In the group of 40-year olds, the value of Ridit by pathological diagnosis was 0.46, 95% CI, 0.45-0.47, that by cytological diagnosis was 0.45, 95% CI, 0.43-0.47. As the age increased at five-year intervals, the value of Ridit increased significantly.

CONCLUSION

In Ci county of a high incidence area of EC, the age definition of high-risk population should be above 45 years.

摘要

目的

明确磁县食管癌高危人群的年龄范围。

方法

采用Ridit法分析2013例受检者的内镜检查结果、16763人的细胞学筛查结果及9265例食管癌患者的病历资料,标准年龄组为45 - 49岁组。

结果

内镜检查中食管上皮中度不典型增生患者的平均年龄为53.5岁,重度不典型增生患者为51.4岁,早期食管癌患者为55.6岁。细胞学筛查中一期重度上皮不典型增生(SEEDI)患者的平均年龄为51.2岁,二期重度食管上皮不典型增生(SEED II)患者为51.6岁,晚期食管癌患者为61.7岁。在40岁组中,病理诊断的Ridit值为0.46,95%可信区间为0.45 - 0.47,细胞学诊断的Ridit值为0.45,95%可信区间为0.43 - 0.47。以5年为间隔随着年龄增加,Ridit值显著升高。

结论

在食管癌高发区磁县,高危人群的年龄界定应为45岁以上。

相似文献

1
Age scope of high-risk population for esophageal cancer in Ci county.
World J Gastroenterol. 2005 Mar 28;11(12):1818-21. doi: 10.3748/wjg.v11.i12.1818.
3
Field population-based blocking treatment of esophageal epithelia dysplasia.
World J Gastroenterol. 2002 Jun;8(3):418-22. doi: 10.3748/wjg.v8.i3.418.
5
[Chemoprevention of esophageal cancer].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1998 Dec;20(6):413-8.
8
Cytologic screening for esophageal cancer in a high-risk population in Anyang County, China.
Acta Cytol. 2002 May-Jun;46(3):445-52. doi: 10.1159/000326859.
9
Associations between cancer family history and esophageal cancer and precancerous lesions in high-risk areas of China.
Chin Med J (Engl). 2022 Apr 5;135(7):813-819. doi: 10.1097/CM9.0000000000001939.
10
Absence of Iodine Staining Associates With Progression of Esophageal Lesions in a Prospective Endoscopic Surveillance Study in China.
Clin Gastroenterol Hepatol. 2020 Jun;18(7):1626-1635.e7. doi: 10.1016/j.cgh.2019.08.058. Epub 2019 Sep 10.

本文引用的文献

1
Endoscopic diagnosis and surveillance of Barrett's esophagus.
Gastrointest Endosc Clin N Am. 2003 Apr;13(2):257-67. doi: 10.1016/s1052-5157(03)00010-2.
3
Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis.
Ann Intern Med. 2003 Feb 4;138(3):176-86. doi: 10.7326/0003-4819-138-3-200302040-00009.
4
An analysis of esophageal cancer incidence in Cixian county from 1974 to 1996.
World J Gastroenterol. 2003 Feb;9(2):209-13. doi: 10.3748/wjg.v9.i2.209.
6
Cytologic screening for esophageal cancer in a high-risk population in Anyang County, China.
Acta Cytol. 2002 May-Jun;46(3):445-52. doi: 10.1159/000326859.
8
Comprehensive prevention and treatment for esophageal cancer.
Chin Med J (Engl). 1999 Oct;112(10):918-23.
9
Cancer statistics, 2001.
CA Cancer J Clin. 2001 Jan-Feb;51(1):15-36. doi: 10.3322/canjclin.51.1.15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验